Rethinking CNS disorders: time for new drug targets?

被引：15
|
作者：
Kalueff, Allan V. [1 ,2 ]
Stewart, Adam Michael [1 ,3 ]
Gottesman, Irving I. [4 ]
机构：
[1] ZENEREI Inst, Slidell, LA 70458 USA
[2] Guangdong Ocean Univ, Res Inst Marine Drugs & Nutr, Zhanjiang 524025, Guangdong, Peoples R China
[3] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA
[4] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 2014年 / 35卷 / 10期
关键词：
ANIMAL-MODELS; ENDOPHENOTYPES;
D O I：
10.1016/j.tips.2014.07.007
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：491 / 492
页数：2
相关论文
共 50 条
  • [31] Challenges with modelling anxiety disorders: a possible hindrance for drug discovery
    Freudenberg, Florian
    O'Leary, Aet
    Aguiar, Daniele C.
    Slattery, David A.
    EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (04) : 279 - 281
  • [32] New Therapeutic Strategy for Mood Disorders
    Crupi, R.
    Marino, A.
    Cuzzocrea, S.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (28) : 4284 - 4298
  • [33] Chronic inflammatory demyelinating polyradiculoneuropathy: A new animal model for new therapeutic targets
    de Seze, J.
    Kremer, L.
    do Rego, C. Alves
    Taleb, O.
    Lam, D.
    Beiano, W.
    Mensah-Nyagan, G.
    Trifilieff, E.
    Brun, S.
    REVUE NEUROLOGIQUE, 2016, 172 (12) : 767 - 769
  • [34] Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date
    Nikiforuk, Agnieszka
    CNS DRUGS, 2015, 29 (04) : 265 - 275
  • [35] True alignment of preclinical and clinical research to enhance success in CNS drug development: a review of the current evidence
    Goetghebeur, Pascal J. D.
    Swartz, Jina E.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (07) : 586 - 594
  • [36] Understanding anti-tuberculosis drug efficacy: rethinking bacterial populations and how we model them
    Evangelopoulos, Dimitrios
    da Fonseca, Joana Diniz
    Waddell, Simon J.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 32 : 76 - 80
  • [37] Dyskinesia and Parkinson's disease: animal model, drug targets, and agents in preclinical testing
    Cesaroni, Valentina
    Blandini, Fabio
    Cerri, Silvia
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (10) : 837 - 851
  • [38] Fungal pathogens research: Novel and improved molecular approaches for the discovery of antifungal drug targets
    Tournu, H
    Serneels, J
    Van Dijck, P
    CURRENT DRUG TARGETS, 2005, 6 (08) : 909 - 922
  • [39] The Evolution of Stem Cells, Disease Modeling, and Drug Discovery for Neurological Disorders
    Pernia, Cameron
    Tobe, Brian T. D.
    O'Donnell, Ryan
    Snyder, Evan Y.
    STEM CELLS AND DEVELOPMENT, 2020, 29 (17) : 1131 - 1141
  • [40] New trends in the neurobiology and pharmacology of affective disorders
    Władysław Lasoń
    Bogusława Budziszewska
    Agnieszka Basta-Kaim
    Marta Kubera
    Michael Maes
    Pharmacological Reports, 2013, 65 : 1441 - 1450
12345